Burlingame, CA, United States of America

Gene G Kinney

This inventor holds 1 USPTO granted patent. Top assignees: Janssen Sciences Ireland Uc, Wyeth. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gene G Kinney. Retrieved from https://idiyas.com/inventor/gene-g-kinney-4ek8e29i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Gene G Kinney

Introduction

Gene G Kinney is a notable inventor based in Burlingame, California. He has made significant contributions to the field of immunotherapy, particularly in relation to Alzheimer's disease. His innovative approach has garnered attention in the scientific community.

Latest Patents

Gene G Kinney holds a patent for the "Use of tau to monitor immunotherapy." This invention provides methods for administering immunotherapy for Alzheimer's and similar diseases, where the treatment regimen is monitored by measuring levels of tau. This advancement has the potential to improve patient outcomes in the management of neurodegenerative diseases.

Career Highlights

Throughout his career, Gene has worked with prominent companies in the pharmaceutical industry. He has been associated with Janssen Sciences Ireland UC and Wyeth, where he contributed to research and development efforts aimed at addressing complex health challenges.

Collaborations

Gene has collaborated with notable professionals in his field, including Ronald Black and Jack Steven Jacobsen. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of therapeutic solutions.

Conclusion

Gene G Kinney's work exemplifies the impact of innovative thinking in the medical field. His contributions to immunotherapy and collaboration with industry leaders highlight the importance of research in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…